A disturbing picture is emerging of a deliberate oversight within the highest levels of the Food and Drug Administration. Evidence suggests officials possessed critical safety information regarding COVID-19 shots in early 2021, yet actively chose to downplay and suppress these concerns.
The revelations came to light during a Senate hearing on April 29th, spearheaded by Senator Ron Johnson. A 39-page interim report, titled “Unmasked: How Biden Health Officials Purposely Turned a Blind Eye Toward COVID-19 Vaccine Signals,” was presented, detailing a pattern of intentional disregard for emerging safety data.
Senator Johnson challenged those listening to assess the report’s accuracy, stating it was “as accurate as it is incriminating.” The core of the issue centers on a flawed data mining system and a concerted effort to avoid creating a transparent record of warnings received by federal health officials.
The report highlights the work of Dr. Ana Szarfman, a senior medical officer at the FDA. Utilizing an updated data analysis technique, she identified dozens of statistically significant safety signals linked to adverse events following COVID-19 vaccination.
Dr. Szarfman immediately shared her findings with relevant FDA officials responsible for vaccine safety monitoring. However, her concerns were largely dismissed, and she was ultimately instructed to halt her data analyses – a move that appears remarkably convenient.
These safety signals weren’t vague possibilities; they pointed to serious risks. The data indicated increased instances of acute myocardial infarction (heart attack) associated with Moderna and Pfizer shots, as well as embolism and thrombosis linked to Janssen and Pfizer vaccines.
Even more alarming, the data flagged a connection between the Pfizer shot and dementia, alongside instances of “Death and sudden death” associated with both Moderna and Pfizer vaccines. This information, instead of prompting immediate investigation and public disclosure, was seemingly sidelined.
Instead of transparency, FDA officials focused on controlling the narrative. By May 2021, Dr. Szarfman was directed to delay her safety reports, fearing they would fuel “anti-vaccination rhetoric.” The priority shifted from protecting public health to managing public perception.
Despite this directive, Dr. Szarfman continued to advocate for her more effective data mining method, emphasizing its ability to detect critical safety signals. Her persistence, however, was met with resistance and her warnings were largely ignored.
The report details instances where even after acknowledging specific risks, like myopericarditis (heart inflammation), officials failed to promptly warn the public about the potential cardiac events associated with the vaccines. Higher statistically significant signals for acute myocardial infarction were also downplayed.
Crucially, the FDA did not adopt Dr. Szarfman’s recommended improvements to their data mining methodology. The existing system, with its known limitations, remained in place, effectively obscuring potentially life-saving information from both the medical community and the public.
